in the striatum and diencephalon. Attention is ca led to possible artifactual interference by myelin basic protein in the immunoassays for fl-endorphin in some regions of the brain. In the pituitary, enkephalin was mainly restricted to the pars intermedia-neurohypophysis. Neither adrenalectomy nor hypophysectomy significantly altered levels of fl-endorphin in brain extracts. Adrenalectomy increased the levels of fl-endorphin in adenohypophysis and pars intermedia-neurohypophysis; after adrenalectomy, enkephalin was also increased in the adenohypophysis but less so in the pars intermedia-neurohypophysis. These results show that brain endorphin levels are independent of pituitary endorphin levels; they suggest that P-endorphincontaining neurons and those containing enkephalin constitute two separate groups of brain cells.
Peptides with opiate-like properties have been isolated from brain and pituitary, and their sequences and structures have been confirmed by complete synthesis (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . The naturally occurring enkephalins and endorphins share common NH2-terminal sequences with COOH-terminal fragments of p-lipotropin (f3-LPH). The various bioassays or receptor-binding assays available (1-6, 11, 12) recognize the various opiate-like peptides as a class, although with different potencies; none of these methods permits the quantitative assessment specifically of any one of the opiate-like peptides. Thus, the nonspecific approaches have left unanswered such questions as whether Met-enkephalin could be no more than a breakdown product of fl-endorphin.
We-have developed specific antisera that can distinguish the enkephalin pentapeptides from a-and j3-endorphin (13) . Using these antisera, we found that significant amounts of f-endorphin exist in brain and that the regional content of ,B-endorphin bears no fixed relationship to the enkephalin content of the same brain regions. We conclude that, in brain and in pituitary, 3-endorphin and enkephalin may be storel within different cells and thus likely are independent entities physiologically.
METHODS
Preparation of Extracts for Radioimmunoassays. Rats (Sprague-Dawley, male, 150-200 g) were killed by decapitation. Pituitary, pineal, and various regions of the brain were dissected rapidly, frozen on dry ice, weighed, and placed in 1 M acetic acid preheated to 95°(2 ml for pituitary, pineal, brain regions; 16 ml for whole brain). After 15 min in the hot bath, samples were chilled in ice and homogenized (Polytron setting 6, 10 sec) and centrifuged (1000 X g, 1 hr). The supernatant was frozen overnight, neutralized to pH 7.5 with 1 M NaOH supplemented with 0.2 M Na2HPO4, and refrozen overnight. Centrifugation (1000 X g, 1 hr) after thawing yielded a clear supernatant that was then used in the radioimmunoassays.
Radioimmunoassays. The radioimmunoassay for fl-endorphin was used as described (13) . A double-antibody radioimmunoassay for Leu5-enkephalin was performed as described here.
A conjugate was prepared by coupling Leu5-enkephalin to bovine serum albumin with bis-diazotized benzidine. Rabbits were immunized with 2 mg of this conjugate plus 5 mg of dried killed Mycobacterium tuberculosis emulsified with complete Freund's adjuvant, by intradermal injections at multiple sites on the back. At 30-day intervals, booster injections with 0.5 mg of conjugate emulsified in incomplete Freund's adjuvant were given. After the second boost, one rabbit of four showed significant immunoreactivity (RB 92-12/76).
Leu5-enkephalin was labeled with 125I by the chloramine-T method, the reaction being stopped with Na metabisulfite. The labeled peptide was purified by chromatography on Sephadex G-25.
Standard doses of peptide or unknown samples were incubated with the antiserum at a final dilution of 1:4900 and with the trace (10,000 cpm of 125I-labeled Leu5-enkephalin) for 25 hr at 40 in a final volume of 0.7 ml of 0.02 M Na phosphate buffer (pH 7.5) containing 145 mM NaCl and 0.1% gelatin. Goat anti-rabbit gamma globulin was used to precipitate antibody-bound trace.
RESULTS AND DISCUSSION
Immunospecificity of the Radioimmunoassay for Enkephalin. As illustrated in Fig. 1 Characterization of fl-Endorphin-Likc Substances. As previously reported (13) , the system used for measurement of f3-endorphi for the Leul4-His27 segment of the molec dorphin is the COOH-terminal 31 amino a LPH, this antiserum also binds on an equ dorphin, f3-LPH, and the 31,000 molecula hormone (13, 15) . Therefore, before procee analysis of the f-endorphin-like immunor present in brain and pituitary extracts, atte separate the immunoreactive component! Extracts of whole rat brains were passed thre column equilibrated and eluted with 4 M I tently, two peaks of immunoreactivity (l-ei munoassay) were resolved (Fig. 3) Gel filtration of rat brain extract. Two rat brains were boiled and homogenized in 32 ml of 1 M acetic acid as described-in Methods. The supernatant (10,000 X g, 30 min) was lyophilized. Two hundred microliters of 4 M guanidine HCl containing 0.02% crystalline bovine serum albumin was added to the dry residue. After boiling for 5 min, the supernatant was applied to the column (45 X 0.7 cm, Bio-Gel P-60) with blue dextran and L-histidine. The column was eluted with 4 M guanidine; 0.3-ml fractions were collected. Kd = (Ve -Vo)/(Vf -V0) in which Ve is the elution volume of the fraction, Vo is the void volume (blue dextran peak: 5 ml), and Vf is the elution volume of the smallest molecule (L-histidine peak: 17 ml).
fl-Endorphin and enkephalin immunoreactivity were assayed by radioimmunoassay (RIA). In another run, 125I-labeled f3-endorphin was applied to the column and the radioactivity was monitored. The elution peaks of Mr 31,000 prohormone (31 K) and of f3-LPH are indicated.
vfet'5-enkephalin, 1 the other peak (amounting to 37% of the total f3-endorphin-like -ephalin.
immunoreactive substance) was eluted in a broad zone of larger e Immunoreactive Mr (10,000-30,000) which did not coincide closely with the radioimmunoassay elution pattern of either f3-LPH or the Mr 31,000 prohormone. in (Fig. 2) medulla (Table 1) . However, no material attributable to the specific f-endorphin component could be found in extracts of neostriatum (caudate/globus pallidus/putamen) or of the cerebral, cerebellar, or hippocampal cortex. These latter regions all contain significant amounts of enkephalin according to others (12, 14, 16, 17) and as confirmed here by our own radioimmunoassay for enkephalin. When the same regions were assayed for 3-endorphin and enkephalin, there was a clear-cut independent variation, from region to region, of the two classes of opioid peptides. Furthermore, when the diencephalon was dissected in accordance with the distribution of immunocytochemically detected jB-endorphin neurons and fibers, the ratio between 3-endorphin and enkephalin values was found to vary from 1.6 in hypothalamus to 9.1 in periaqueductal thalamus (Table 2 ). In addition, globus pallidus and caudate nucleus, which contain large numbers of immunocytochemically detected enkephalin fibers, contained virtually no f-endorphin. Thus, these data strongly suggest that f3-endorphin and enkephalin are found in the brain within different neuronal systems.
Relationships between Endorphin and Enkephalin Im- (Table 1) .
To pursue further the relationships between fl-endorphin and enkephalin in brain and pituitary, radioimmunoassays for each were performed on tissues from rats after long-term hypophysectomy and adrenalectomy. In brain, neither treatment altered significantly the amount of f-endorphin immunoreactive substance attributable to authentic ,B-endorphin (Table  3) . In the adenohypophysis, there was a significant increase of both 3-endorphin and enkephalin immunoassayable materials (15) . Indeed, ,B-LPH has been reported to be present in bovine brain (19, 20) in striatal and cortical regions (19) which, in the rat, show exclusively the Mr 10,000-3,000 components. However, as mentioned above, the larger material found in striatal and cortical regions could also be myelin basic protein (unpublished data). Results of the radioimmunoassays must therefore be interpreted with caution; it is pertinent to add that highly purified myelin basic protein (ovine or porcine origin) has no opiate-like activity in the myenteric plexus/longitudinal muscle of the guinea pig's ileum.
Finally, the data offered here speak more broadly to the issue of the so-called opiate-receptors, the characterization of which began the effort that led to the isolation of the enkephalins and endorphins. If fl-endorphin-and enkephalin-containing cell systems are anatomically separable, as well as biochemically distinct, the logical expectation might be that postsynaptic receptors for the two systems would also show possible pharmacological separation. In this regard it will be important to probe areas rich in one opioid peptide and poor in another for discriminable patterns of cellular responsivity (21) to the gamut of synthetic morphinomimetic peptides now available.
